ISSF

Inside ISSF

Home
Inside ISSF
Anti-Doping
Information Portal on Doping - IPOD
Anti-Doping and Clean Sport
Therapeutic Use Exemption
Information Portal on Doping - IPOD
News
FAQ
ISSF Outreach Posters
Education and Awareness
WADA
2021 World Anti Doping Code
ADAMS
International Standards
2024 Prohibited List
2024 Summary
2024 Monitoring Program

IPOD Articles

Articles 2024

1.2024-IPOD-2-Prohibited-List-2025.pdf
2.2024-IPOD-1-OG-edition.pdf

Articles 2023

1.2023-IPOD-5-2023-Year-End-Report.pdf
2.2023-IPOD-4-Prohibited-List.pdf
3.2023-IPOD-3-Reminders-about-the-risks-associated-with-supplement-use.pdf
4.2023-IPOD-2_2022-Year-End-Report.pdf
5.2023-IPOD-1st-Edition-2023-ADEL-Resources.pdf

Articles 2022

1.2022_IPOD-6_WADA-Prohibited-List-2023.pdf
2.2022_IPOD-5_Education-on-Privacy-and-Information-Security-Awareness.pdf
3.2022_IPOD-4_Reminders-about-the-risks-associated-with-supplement-use.pdf
4.2022_IPOD-3_Webinar-for-athletes-on-the-List-and-TUEs.pdf
5.2022_IPOD-2_Key-areas-of-athlete-vulnerabilities-to-doping.pdf
6.2022_IPOD-1_2021-Year-End-Report.pdf

Articles 2021

1.2021_IPOD-3_2022-Prohibited-List.pdf
2.2021_IPOD-2_Important-anti-doping-reminders-before-Tokyo-OGs.pdf
3.2021_IPOD-1_2020-Year-End-Report.pdf

Articles 2020

1.2020_IPOD-3_2021-Prohibited-List.pdf
2.2020_IPOD-2_Notice-on-revised-ISSF-Anti-Doping-Rules-coming-into-effect-January-1-2021.pdf
3.2020_IPOD-1_2019-Year-End-Report.pdf

Articles 2019

1.2019_IPOD-6_2020-Prohibited-List.pdf
2.2019_IPOD-5_Reminders-to-Athletes-on-risks-of-taking-supplements.pdf
3.2019_IPOD-4_Reminders-to-Verify-Medication.pdf
4.2019_IPOD-3_Roles-Responsibilities-and-Duties-of-all-ISSF-Athletes.pdf
5.2019_IPOD-2_Therapeutic-Use-Exemptions.pdf
6.2019_IPOD-1_Risks-of-supplement-use-and-Inadvertent-doping.pdf

Articles 2018

1.2018_IPOD-6_Youth-Olympic-Games-ISSF-Focus-Day.pdf
2.2018_IPOD-5_Testing-at-the-Changwon-World-Championships.pdf
3.2018_IPOD-4_Focus-on-the-WADA-Athletes-Committee.pdf
4.2018_IPOD-3_ADEL-the-new-Anti-Doping-E-Learning-Platform.pdf
5.2018_IPOD-2_Monitoring-Compliance-to-the-ISSF-Anti-Doping-Rules-and-the-World-Anti-Doping-Code.pdf
6.2018_IPOD-1_2017-Anti-Doping-Report-and-Looking-Ahead-to-2018.pdf

Articles 2017

1.2017_IPOD-6_The-ISSF-Anti-Doping-Committee-and-Code-Compliance.pdf
2.2017_IPOD-5_An-Ongoing-Debate.pdf
3.2017_IPOD-4_Speaking-Out-on-Doping.pdf
4.2017_IPOD-3_ISSF-Compliance-with-the-World-Anti-Doping-Code.pdf
5.2017_IPOD-2_Test-Your-Anti-Doping-Knowledge.pdf
6.2017_IPOD-1_2016-Anti-Doping-Report-and-Looking-Ahead-to-2017.pdf

Articles 2016

1.2016_IPOD-6_Privacy-Issues-in-Anti-Doping.pdf
2.2016_IPOD-4_Take-the-Anti-Doping-Quiz.pdf
3.2016_IPOD-3_The-IPOD-answers-questions-on-Meldonium-and-Jurisdiction-over-Athletes-at-the-OGs.pdf
4.2016_IPOD-2_Education-and-Awareness-Successful-Anti-Doping-Programs.pdf
5.2016_IPOD-1_2015-Anti-Doping-Report-and-Looking-ahead-to-2016.pdf

Articles 2015

1.2015_IPOD-6_Prohibited-Association-Explained.pdf
2.2015_IPOD-5_Substantial-Assistance-Explained.pdf
3.2015_IPOD-4_Interview-with-ISSF-Athletes-Committee-Chairman-Abhinav-Bindra.pdf
4.2015_IPOD-3_The-WADA-ADO-Symposium-Intelligence-Based-Testing-The-ISSF-RTP.pdf
5.2015_IPOD-2_The-IPOD-answers-questions-on-Supplements-Use-and-TUEs.pdf
6.2015_IPOD-1_2014-Anti-Doping-Report-and-looking-ahead-to-2015.pdf

Articles 2014

1.2014_IPOD-6_The-2015-ISSF-Anti-Doping-Rules.pdf
2.2014_IPOD-5_Therapeutic-Use-Exemptions-Process.pdf
3.2014_IPOD-4_A-New-and-Revised-World-Anti-Doping-Code.-Part-III.pdf
4.2014_IPOD-3_A-New-and-Revised-World-Anti-Doping-Code.-Part-II.pdf
5.2014_IPOD-2_A-New-and-Revised-World-Anti-Doping-Code.-Part-I.pdf
6.2014_IPOD-1_2013-Anti-Doping-Report.pdf

Articles 2013

1.2013_IPOD-6_Looking-head-to-2014.pdf
2.2013_IPOD-5_The-IPOD-answers-3-questions-from-its-readers.pdf
3.2013_IPOD-4_The-IPOD-answers-6-questions-from-its-readers.pdf
4.2013_IPOD-3_ISSFs-Role-in-Anti-Doping-Education-and-Prevention.pdf
5.2013_IPOD-2_WADA-Accredited-Laboratories-for-Doping-Control-Analysis.pdf
6.2013_IPOD-1_2012-Anti-Doping-Report-and-looking-ahead-to-2013.pdf

Articles 2012

1.2012_IPOD-5_2013-Prohibited-List.pdf
2.2012_IPOD-4_Anti-Doping-at-the-2012-Summer-Olympic-Games-in-London.pdf
3.2012_IPOD-3_Focus-on-Regional-Anti-Doping-Organisations-RADOs.pdf
4.2012_IPOD-2_World-Anti-Doping-Code-review-process-and-Risks-of-Supplements.pdf
5.2012_IPOD-1_2011-Anti-Doping-Report.pdf

Articles 2011

1.2011_IPOD-6_2012-Prohibited-List.pdf
2.2011_IPOD-5_Supplements-Risks-vs-Rewards.pdf
3.2011_IPOD-4_The-IPOD-answers-3-questions-from-its-readers.pdf
4.2011_IPOD-3_The-IPOD-answers-2-questions-from-its-readers.pdf
5.2011_IPOD-2_The-IPOD-answers-3-questions-from-its-readers.pdf
6.2011_IPOD-1_2010-Anti-Doping-Report.pdf

Articles 2010

1.2010_IPOD-6_Looking-ahead-to-ISSFs-Anti-Doping-Initiatives-for-2011.pdf
2.2010_IPOD-5_Focus-on-the-ISSF-Medical-Committee.pdf
3.2010_IPOD-4_The-Importance-of-Anti-Doping-Education.pdf
4.2010_IPOD-3_Focus-on-WADA-the-World-Anti-Doping-Agency.pdf
5.2010_IPOD-2_The-WADA-Prohibited-List.pdf
6.2010_IPOD-1_2009-Anti-Doping-Report.pdf

Articles 2009

1.2009_IPOD-6_The-IOC-Medical-Commission-and-WADA.pdf
2.2009_IPOD-5_Beware-of-Beta-Blockers.pdf
3.2009_IPOD-4_Abbreviated-Therapeutic-Use-Exemptions.pdf
4.2009_IPOD-3_Q-A-on-Therapeutic-Use-Exemptions.pdf
5.2009_IPOD-2_Q-A-on-Prohibited-Substances-the-IPOD-quiz.pdf